An international team of including the Lomonosov Moscow State University researchers discovered which enzyme enables Escherichia coli bacterium (E. coli) to breathe. The study is published in the Scientific Reports.
There is a prospect of a new type of antibiotics “turning off” the oxygen only to the harmful bacteria cells, not to human cells.
Scientists discovered how the E. coli bacterium can survive in the human gut – earlier the question how they breathe was a mystery to experts. Vitaliy Borisov, Senior Researcher, Doctor of Biological Sciences, Professor of the Russian Academy of Sciences, A.N. Belozersky Research Institute physical and chemical biology employee, the Lomonosov Moscow State University and one of the authors, explains that breathing E. coli uses special enzymes, which are absent in the human body. This means that the discovery of the scientists can contribute to the creation of new drugs, which will be detrimental to the bacteria without harming a human.
The energy for the vital activity of any organism comes from food, and is generated by the means of redox processes in the body. The food is converted into energy not directly but through intermediaries. First, the complex molecules are decomposed into simpler: proteins are decomposed into amino acids, fats – to fatty acids, carbohydrates – to monosaccharides. Oxidation of simpler molecules releases energy, which all is contained in the electrons.
The electrons passes to the respiratory chain with the so-called reducing equivalents (electron-carrying compound). They are NADH (nicotinamide adenine dinucleotide) and ubiquinol, also known as coenzyme Q. These two basic reducing equivalents fully cope with the processing of food: NADH is a water-soluble compound and ubiquinol is fat-soluble. Membranous enzymes accept electrons from reducing equivalents and transfer them to molecular oxygen.
The terminal cytochrome oxidase is the main membrane enzyme responsible for the human mitochondrial respiration and was thought to be used for the breath of E. coli as well. The scheme of oxidases action is simple: transferring electrons to molecular oxygen, reducing equivalents are oxidized again, and as a result “the energy currency” of the cell – the proton-moving force is generated.
‘If you stop breathing, you die just because oxygen does not flow to the oxidase, and it does not produce energy,’ said Vitaly Borisov.
The Escherichia coli bacterium lives in the gastrointestinal tract, where a lot of hydrogen sulfide is produced, which attenuates mitochondrial respiration. Free hydrogen sulfide inhibits cytochrome oxidase work. Its concentration exceeds several hundred times the minimum concentration required for substantial blocking of this enzyme. Hence, it seems that the E. coli bacterium cannot “breathe”, but despite that the bacteria somehow survive in the intestine. The researchers assumed that the breath in the presence of hydrogen sulfide is still possible, but due to other oxidase. The fact is that the breath in people and bacteria occur in different ways. Each cell in our body “breathes” due to the work of only the cytochrome-c oxidase, others we have not. However, the E. coli bacteria has two types of oxidase: bo-type cytochrome oxidase (analogue of “human” cytochrome-c oxidase) and completely different bd-type cytochromes.
‘Our hypothesis was that the bd-type oxidase (bd-I and bd-II) are more resistant to the hydrogen sulfide inhibition than the bo-type cytochrome oxidase,’ commented Vitaly Borisov.
To test this hypothesis scientists needed to learn how the sulfide presence in the environment affects the growth of the E. coli bacteria cells, which have only one terminal oxidase (bd-I, bd-II or bo) in the respiratory chain. a variety of biochemical, biophysical and microbiological methods and approaches were applied, as well as the method of the intended mutagenesis.
The hypothesis was fully confirmed.
‘Bo-oxidase’s activity is completely inhibited by the hydrogen sulfide, while the work of the bd-oxidases remains untouched by the H2S. Thus, in order to successfully produce the main types of “the energy currency” under a high concentration of hydrogen sulfide, the intestinal microflora inhabitants should use a unique type of terminal oxidases, which is missing in the cells of humans and animals,’ said Vitaly Borisov.
The discovery could be used in the future to develop medicines that regulate the intestinal microflora and relieving it from harmful bacteria. As human cells do not contain the bd-type oxidase, the question of the ability to combat disease-causing bacteria without causing harm to the human body becomes relevant. For example, the bacterium causing tuberculosis, which’s primarily membrane enzyme is also a bd-type oxidase, quickly gaining resistance to classical antibiotics. Through this study there is a prospect of a new type of antibiotics “turning off” the oxygen only to the harmful bacteria cells, not to human cells.
Learn more:Â Revolutionary Antibiotics that Will Save the World?
The Latest on: Revolutionary Antibiotics
[google_news title=”” keyword=”Revolutionary Antibiotics” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Revolutionary Antibiotics
- CRISPR-Cas Gene Editing Help Combat Antimicrobial Resistanceon April 29, 2024 at 11:08 am
Despite rising global antimicrobial resistance (AMR), researchers highlight CRISPR/Cas systems' potential in antimicrobial agent development.
- Can CRISPR-Cas gene editing tech fight antimicrobial resistance?on April 28, 2024 at 11:18 am
CRISPR-Cas, the Nobel Prize-winning gene-editing technology, has the potential to target resistance genes and make bacteria sensitive to first-line antibiotics again, according to a study.
- Experts developing immune-enhancing therapies to treat TB: Studyon April 28, 2024 at 9:33 am
Experts are developing revolutionary immune-enhancing medicines known as host-directed therapies, which employ the body's immune system to target TB, to tackle even drug-resistant strains of the ...
- No Antibiotics Needed – Revolutionary Chronic Wound Treatment Could Help Millionson April 28, 2024 at 1:29 am
An international team of scientists has developed a new treatment for chronic wounds that uses ionized gas to activate a wound dressing, without the need for antibiotics. The treatment involves the pl ...
- ‘Just in case’ use of antibiotics was rife during COVID-19, says UN health agencyon April 26, 2024 at 3:37 am
Antibiotics saw “extensive overuse” globally among hospitalized COVID-19 patients during the pandemic without improving clinical outcomes, while also potentially exacerbating the already serious and ...
- Antibiotic Breakthrough: Revolutionary Chinese Study Paves Way for Superbug Defeating Drugson April 23, 2024 at 2:43 pm
New research reveals that fluorous lipopetides act as highly effective antibiotics. Bacterial infections resistant to multiple drugs, which no existing antibiotics can treat, represent a significant ...
- Study Finds Antibiotics Helps Immune Cells Identify Cancer Cellson April 16, 2024 at 5:01 pm
However, many patients get little or no benefit from these revolutionary treatments ... researchers from Osaka University have discovered that tetracycline antibiotics help the immune system to find ...
- Antibiotics reveal a new way to fight canceron April 16, 2024 at 12:42 pm
However, many patients get little or no benefit from these revolutionary treatments ... Osaka University have discovered that tetracycline antibiotics help the immune system to find cancer ...
- Antibiotics reveal a new way to fight canceron April 15, 2024 at 5:00 pm
However, many patients get little or no benefit from these revolutionary treatments ... "We investigated the tetracycline antibiotic minocycline in blood and tumor tissue from lung cancer patients ...
via Bing News